These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 23553968

  • 1. Percutaneous ventricular septal defect closure with Amplatzer devices resulting in severe tricuspid regurgitation.
    Matyal R, Wang A, Mahmood F.
    Catheter Cardiovasc Interv; 2013 Nov 15; 82(6):E817-20. PubMed ID: 23553968
    [Abstract] [Full Text] [Related]

  • 2. Does the placement of an Amplatzer septal occluder device confer benefit in patients with a post-infarction ventricular septal defect?
    Dawson AG, Williams SG, Cole D.
    Interact Cardiovasc Thorac Surg; 2014 Dec 15; 19(6):1040-7. PubMed ID: 25193971
    [Abstract] [Full Text] [Related]

  • 3. Medium to long-term echo follow-up after ventricular septal defect device closure.
    Rahmath MR, Numan M, Dilawar M.
    Asian Cardiovasc Thorac Ann; 2016 Jun 15; 24(5):422-7. PubMed ID: 27112358
    [Abstract] [Full Text] [Related]

  • 4. Percutaneous transcatheter aortic valve closure successfully treats left ventricular assist device-associated aortic insufficiency and improves cardiac hemodynamics.
    Parikh KS, Mehrotra AK, Russo MJ, Lang RM, Anderson A, Jeevanandam V, Freed BH, Paul JD, Karol J, Nathan S, Shah AP.
    JACC Cardiovasc Interv; 2013 Jan 15; 6(1):84-9. PubMed ID: 23347865
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Long-term efficacy of transcatheter closure of ventricular septal defect in combination with percutaneous coronary intervention in patients with ventricular septal defect complicating acute myocardial infarction: a multicentre study.
    Zhu XY, Qin YW, Han YL, Zhang DZ, Wang P, Liu YF, Xu YW, Jing QM, Xu K, Gersh BJ, Wang XZ.
    EuroIntervention; 2013 Mar 15; 8(11):1270-6. PubMed ID: 23538156
    [Abstract] [Full Text] [Related]

  • 7. Percutaneous repair of post-myocardial infarction ventricular septal defect: current approaches and future perspectives.
    Baldasare MD, Polyakov M, Laub GW, Costic JT, McCormick DJ, Goldberg S.
    Tex Heart Inst J; 2014 Dec 15; 41(6):613-9. PubMed ID: 25593526
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Early migration of an Amplatzer muscular ventricular septal defect occluder device causing severe tricuspid valve obstruction.
    Panduranga P, Al-Farqani A, Al-Maskari S.
    J Cardiovasc Med (Hagerstown); 2012 May 15; 13(5):336-7. PubMed ID: 22089813
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Disappearing high velocity severe tricuspid regurgitation following Ventricular septal defect device closure.
    Kumar V, Aggarwal N, Swamy A, Garg S.
    Indian Heart J; 2017 May 15; 69(3):402-404. PubMed ID: 28648440
    [Abstract] [Full Text] [Related]

  • 13. Severe aortic valve regurgitation after percutaneous ventricular septal defect closure.
    Fouilloux V, Kreitmann B.
    Catheter Cardiovasc Interv; 2012 Nov 15; 80(6):944-5. PubMed ID: 22431277
    [Abstract] [Full Text] [Related]

  • 14. Transcatheter closure of congenital and acquired muscular ventricular septal defects using the Amplatzer device.
    Chessa M, Carminati M, Cao QL, Butera G, Giusti S, Bini RM, Hijazi ZM.
    J Invasive Cardiol; 2002 Jun 15; 14(6):322-7. PubMed ID: 12042624
    [Abstract] [Full Text] [Related]

  • 15. [Efficacy of the transcatheter closure of perimembranous and muscular ventricular septal defects with the Amplatzer duct occluder II].
    Zhao PJ, Yu ZQ, Gao W, Li F, Fu LJ, Liu TL, Li Y, Zhang YQ, Huang MR, Guo Y.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Oct 15; 40(10):817-20. PubMed ID: 23302666
    [Abstract] [Full Text] [Related]

  • 16. Percutaneous closure of symptomatic large tricuspid paravalvular regurgitation using two muscular VSD occluders.
    Mukherji A, Anantharaman R, Subramanyan R.
    Indian Heart J; 2017 Oct 15; 69(3):334-337. PubMed ID: 28648426
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Perventricular device closure of perimembranous ventricular septal defect in pediatric patients: technical and morphological considerations.
    Zhu D, Gan C, Li X, An Q, Luo S, Tang H, Feng Y, Lin K.
    Thorac Cardiovasc Surg; 2013 Jun 15; 61(4):300-6. PubMed ID: 23564538
    [Abstract] [Full Text] [Related]

  • 20. Traumatic ventricular septal defect and flail tricuspid valve: successful management by an extracorporeal membrane oxygenator-supported hybrid approach.
    Ling FS, Massey HT.
    Catheter Cardiovasc Interv; 2014 Mar 01; 83(4):655-60. PubMed ID: 23728953
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.